Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Development of new cancers in patients with DCIS: the M.D. Anderson experience
Annals of Surgical Oncology, 02/05/08
Dawood S et al. - In a study to describe clinical characteristics and outcome of mammographically and clinically detected new cancers in patients with previously diagnosed ductal carcinoma in situ (DCIS), it was shown that second events following DCIS occur primarily in the opposite breast and have a negative impact on survival
Methods- A database was searched to identify patients with a primary diagnosis of DCIS
- Patients with prior evidence of invasive carcinoma were excluded from the analysis
- Cumulative incidence of new cancers was estimated according to the method of Gray
- 799 patients diagnosed and treated for DCIS were included in the analysis
- Median age at diagnosis was 54 years and median tumor size was 1.4 cm
- After a median follow-up of 2.9 years, 45 patients had a second event: 14 with in-situ and 31 with invasive disease
- Median disease-free interval was 3.5 years
- The majority of second events occurred in the opposite breast and the cumulative incidence at 5 years was 6.6%
- Overall survival at 5 years was 97.4%; that for the second event was 76.1%
- For mammography and self-palpation, respectively, the 5-year survival by method of detection of the second event was 63.2% and 100%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatocyte Nuclear Factor-4–Independent Synthesis of Coagulation Factor VII in Breast Cancer Cells and Its Inhibition by Targeting Selective Histone Acetyltransferases
Molecular Cancer Research, 12/11/09
Tamoxifen Inhibits TRPV6 Activity via Estrogen Receptor–Independent Pathways in TRPV6-Expressing MCF-7 Breast Cancer Cells
Molecular Cancer Research, 12/11/09
Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients
Cancer Immunology, Immunotherapy, 12/11/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Annals of Diagnostic Pathology, 12/11/09
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
British Journal of Cancer, 12/11/09
Diagnosis of platelet-type von Willebrand disease by flow cytometry
Haematologica, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


